UnitedHealth Group (NYSE:UNH) Shares Acquired Rep. Tim Moore

Representative Tim Moore (R-North Carolina) recently bought shares of UnitedHealth Group Incorporated (NYSE:UNH). In a filing disclosed on September 03rd, the Representative disclosed that they had bought between $15,001 and $50,000 in UnitedHealth Group stock on August 8th.

Representative Tim Moore also recently made the following trade(s):

• Sold $100,001 – $250,000 in shares of Centene (NYSE:CNC) on 8/18/2025.
• Sold $50,001 – $100,000 in shares of UnitedHealth Group (NYSE:UNH) on 8/15/2025.
• Sold $100,001 – $250,000 in shares of Intel (NASDAQ:INTC) on 8/13/2025.
• Sold $50,001 – $100,000 in shares of Hyster-Yale (NYSE:HY) on 8/13/2025.
• Purchased $15,001 – $50,000 in shares of Hyster-Yale (NYSE:HY) on 8/12/2025.
• Purchased $15,001 – $50,000 in shares of Intel (NASDAQ:INTC) on 8/11/2025.
• Purchased $1,001 – $15,000 in shares of Centene (NYSE:CNC) on 8/8/2025.
• Purchased $15,001 – $50,000 in shares of Intel (NASDAQ:INTC) on 8/8/2025.
• Purchased $15,001 – $50,000 in shares of Hyster-Yale (NYSE:HY) on 8/7/2025.
• Purchased $15,001 – $50,000 in shares of Centene (NYSE:CNC) on 8/7/2025.

UnitedHealth Group Stock Performance

Shares of NYSE UNH opened at $309.98 on Friday. The company has a market cap of $280.74 billion, a P/E ratio of 13.43, a P/E/G ratio of 1.99 and a beta of 0.45. UnitedHealth Group Incorporated has a 52-week low of $234.60 and a 52-week high of $630.73. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85. The firm’s fifty day moving average is $288.66 and its two-hundred day moving average is $375.70.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing the consensus estimate of $4.45 by ($0.37). The company had revenue of $111.62 billion during the quarter, compared to analysts’ expectations of $111.75 billion. UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The company’s revenue was up 12.9% on a year-over-year basis. During the same quarter in the prior year, the business posted $6.80 EPS. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. As a group, analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th will be issued a $2.21 dividend. This represents a $8.84 dividend on an annualized basis and a yield of 2.9%. The ex-dividend date is Monday, September 15th. UnitedHealth Group’s payout ratio is currently 38.30%.

Analyst Upgrades and Downgrades

Several brokerages recently commented on UNH. HSBC reiterated a “reduce” rating and set a $270.00 price target (down from $490.00) on shares of UnitedHealth Group in a report on Wednesday, May 21st. Mizuho dropped their price objective on shares of UnitedHealth Group from $515.00 to $350.00 and set an “outperform” rating on the stock in a research note on Friday, May 16th. Deutsche Bank Aktiengesellschaft reduced their price target on UnitedHealth Group from $521.00 to $362.00 and set a “buy” rating on the stock in a research report on Wednesday, May 14th. Robert W. Baird reaffirmed an “underperform” rating and issued a $198.00 price target (down previously from $312.00) on shares of UnitedHealth Group in a report on Thursday, July 31st. Finally, Wolfe Research reduced their target price on shares of UnitedHealth Group from $501.00 to $390.00 and set an “outperform” rating for the company in a report on Tuesday, May 20th. Fifteen investment analysts have rated the stock with a Buy rating, six have given a Hold rating and three have given a Sell rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $353.71.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently added to or reduced their stakes in UNH. LFA Lugano Financial Advisors SA acquired a new position in UnitedHealth Group during the 2nd quarter worth approximately $25,000. Bayforest Capital Ltd raised its position in UnitedHealth Group by 685.7% during the 1st quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate’s stock worth $29,000 after buying an additional 48 shares during the last quarter. Sagard Holdings Management Inc. purchased a new stake in shares of UnitedHealth Group in the second quarter valued at approximately $29,000. Islay Capital Management LLC purchased a new position in shares of UnitedHealth Group in the 2nd quarter valued at about $31,000. Finally, Clal Insurance Enterprises Holdings Ltd increased its holdings in shares of UnitedHealth Group by 416.7% in the 1st quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate’s stock valued at $32,000 after purchasing an additional 50 shares in the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

Insider Activity at UnitedHealth Group

In other news, CEO Patrick Hugh Conway sold 589 shares of UnitedHealth Group stock in a transaction dated Tuesday, June 10th. The shares were sold at an average price of $305.00, for a total transaction of $179,645.00. Following the completion of the sale, the chief executive officer directly owned 10,398 shares in the company, valued at $3,171,390. The trade was a 5.36% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. 0.28% of the stock is currently owned by company insiders.

About Representative Moore

Timothy K. Moore (Republican Party) is a member of the U.S. House, representing North Carolina’s 14th Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027.

Moore (Republican Party) ran for election to the U.S. House to represent North Carolina’s 14th Congressional District. He won in the general election on November 5, 2024.

Moore served as speaker of the House from 2015 to 2025.

Timothy Moore earned his B.A. from the University of North Carolina-Chapel Hill in 1992 and his J.D. from the Oklahoma City University School of Law in 1995. His professional experience includes working as an attorney.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.